Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Read Simon sold 2,777 Dianthus Therapeutics, Inc. shares (Form 4)
Traded Aug 10, 2026 · Filed Aug 11, 2026
On Aug 10, 2026, Read Simon (Director) sold 2,777 Dianthus Therapeutics, Inc. shares at an average US$109.55 for US$304K under a trading plan, leaving 0 shares. Filed Aug 11, 2026 (Form 4).
- Sold
- 2,777 shares
- Price
- US$109.55 average (US$107.11 to US$111.77)
- Value
- US$304K
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Option exercise | 2,777 | US$18.36 | 2,777 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 70 | US$107.11 | 2,707 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 737 | US$108.17 | 1,970 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 831 | US$108.95 | 1,139 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 272 | US$109.96 | 867 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 470 | US$111.05 | 397 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 397 | US$111.77 | 0 | Direct |
Source
Related
- Dianthus Therapeutics, Inc.
- Read Simon
- Dianthus Therapeutics, Inc. shareholders
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G · Wellington Management Group LLP · Aug 13, 2026